Global Polio Vaccine Market Growth 2020-2025

  • receipt Report ID : 139465
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 135
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the Polio Vaccine market will register a 5.5%% CAGR in terms of revenue, the global market size will reach $ 1638.1 million by 2025, from $ 1322.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Polio Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Polio Vaccine, covering the supply chain analysis, impact assessment to the Polio Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Polio Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Public

Private

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Sanofi

GSK

Serum Institute

Tiantan Biological

Bibcol

Bio-Med

IMBCA

Halfkin Bio-Pharmaceuticals

Panacea Biotec Ltd

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Polio Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Polio Vaccine market by identifying its various subsegments.

Focuses on the key global Polio Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Polio Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Polio Vaccine submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Polio Vaccine Consumption 2015-2025

2.1.2 Polio Vaccine Consumption CAGR by Region

2.2 Polio Vaccine Segment by Type

2.2.1 Inactivated Polio Vaccine (IPV)

2.2.2 Oral Polio Vaccine (OPV)

2.3 Polio Vaccine Consumption by Type

2.3.1 Global Polio Vaccine Consumption Market Share by Type (2015-2020)

2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2015-2020)

2.3.3 Global Polio Vaccine Sale Price by Type (2015-2020)

2.4 Polio Vaccine Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Polio Vaccine Consumption by Application

2.5.1 Global Polio Vaccine Consumption Market Share by Type (2015-2020)

2.5.2 Global Polio Vaccine Value and Market Share by Type (2015-2020)

2.5.3 Global Polio Vaccine Sale Price by Type (2015-2020)

3 Global Polio Vaccine by Company

3.1 Global Polio Vaccine Sales Market Share by Company

3.1.1 Global Polio Vaccine Sales by Company (2018-2020)

3.1.2 Global Polio Vaccine Sales Market Share by Company (2018-2020)

3.2 Global Polio Vaccine Revenue Market Share by Company

3.2.1 Global Polio Vaccine Revenue by Company (2018-2020)

3.2.2 Global Polio Vaccine Revenue Market Share by Company (2018-2020)

3.3 Global Polio Vaccine Sale Price by Company

3.4 Global Polio Vaccine Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Polio Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Polio Vaccine by Regions

4.1 Polio Vaccine by Regions

4.2 Americas Polio Vaccine Consumption Growth

4.3 APAC Polio Vaccine Consumption Growth

4.4 Europe Polio Vaccine Consumption Growth

4.5 Middle East & Africa Polio Vaccine Consumption Growth

5 Americas

5.1 Americas Polio Vaccine Consumption by Countries

5.1.1 Americas Polio Vaccine Consumption by Countries (2015-2020)

5.1.2 Americas Polio Vaccine Value by Countries (2015-2020)

5.2 Americas Polio Vaccine Consumption by Type

5.3 Americas Polio Vaccine Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Polio Vaccine Consumption by Regions

6.1.1 APAC Polio Vaccine Consumption by Regions (2015-2020)

6.1.2 APAC Polio Vaccine Value by Regions (2015-2020)

6.2 APAC Polio Vaccine Consumption by Type

6.3 APAC Polio Vaccine Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Polio Vaccine by Countries

7.1.1 Europe Polio Vaccine Consumption by Countries (2015-2020)

7.1.2 Europe Polio Vaccine Value by Countries (2015-2020)

7.2 Europe Polio Vaccine Consumption by Type

7.3 Europe Polio Vaccine Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Polio Vaccine by Countries

8.1.1 Middle East & Africa Polio Vaccine Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Polio Vaccine Value by Countries (2015-2020)

8.2 Middle East & Africa Polio Vaccine Consumption by Type

8.3 Middle East & Africa Polio Vaccine Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Polio Vaccine Distributors

10.3 Polio Vaccine Customer

11 Global Polio Vaccine Market Forecast

11.1 Global Polio Vaccine Consumption Forecast (2021-2025)

11.2 Global Polio Vaccine Forecast by Regions

11.2.1 Global Polio Vaccine Forecast by Regions (2021-2025)

11.2.2 Global Polio Vaccine Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Polio Vaccine Forecast by Type

11.8 Global Polio Vaccine Forecast by Application

12 Key Players Analysis

12.1 Sanofi

12.1.1 Company Information

12.1.2 Polio Vaccine Product Offered

12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Sanofi Latest Developments

12.2 GSK

12.2.1 Company Information

12.2.2 Polio Vaccine Product Offered

12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 GSK Latest Developments

12.3 Serum Institute

12.3.1 Company Information

12.3.2 Polio Vaccine Product Offered

12.3.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Serum Institute Latest Developments

12.4 Tiantan Biological

12.4.1 Company Information

12.4.2 Polio Vaccine Product Offered

12.4.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Tiantan Biological Latest Developments

12.5 Bibcol

12.5.1 Company Information

12.5.2 Polio Vaccine Product Offered

12.5.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Bibcol Latest Developments

12.6 Bio-Med

12.6.1 Company Information

12.6.2 Polio Vaccine Product Offered

12.6.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Bio-Med Latest Developments

12.7 IMBCA

12.7.1 Company Information

12.7.2 Polio Vaccine Product Offered

12.7.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 IMBCA Latest Developments

12.8 Halfkin Bio-Pharmaceuticals

12.8.1 Company Information

12.8.2 Polio Vaccine Product Offered

12.8.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Halfkin Bio-Pharmaceuticals Latest Developments

12.9 Panacea Biotec Ltd

12.9.1 Company Information

12.9.2 Polio Vaccine Product Offered

12.9.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Panacea Biotec Ltd Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Polio Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Inactivated Polio Vaccine (IPV)

Table 5. Major Players of Oral Polio Vaccine (OPV)

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Polio Vaccine Consumption Market Share by Type (2015-2020)

Table 8. Global Polio Vaccine Revenue by Type (2015-2020) ($ million)

Table 9. Global Polio Vaccine Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Polio Vaccine Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Polio Vaccine Consumption Market Share by Application (2015-2020)

Table 13. Global Polio Vaccine Value by Application (2015-2020)

Table 14. Global Polio Vaccine Value Market Share by Application (2015-2020)

Table 15. Global Polio Vaccine Sale Price by Application (2015-2020)

Table 16. Global Polio Vaccine Sales by Company (2017-2019) (M Doses)

Table 17. Global Polio Vaccine Sales Market Share by Company (2017-2019)

Table 18. Global Polio Vaccine Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Polio Vaccine Revenue Market Share by Company (2017-2019)

Table 20. Global Polio Vaccine Sale Price by Company (2017-2019)

Table 21. Global Polio Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Polio Vaccine Products Offered

Table 23. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Polio Vaccine Consumption by Regions 2015-2020 (M Doses)

Table 25. Global Polio Vaccine Consumption Market Share by Regions 2015-2020

Table 26. Global Polio Vaccine Value by Regions 2015-2020 ($ Millions)

Table 27. Global Polio Vaccine Value Market Share by Regions 2015-2020

Table 28. Americas Polio Vaccine Consumption by Countries (2015-2020) (M Doses)

Table 29. Americas Polio Vaccine Consumption Market Share by Countries (2015-2020)

Table 30. Americas Polio Vaccine Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Polio Vaccine Value Market Share by Countries (2015-2020)

Table 32. Americas Polio Vaccine Consumption by Type (2015-2020) (M Doses)

Table 33. Americas Polio Vaccine Consumption Market Share by Type (2015-2020)

Table 34. Americas Polio Vaccine Consumption by Application (2015-2020) (M Doses)

Table 35. Americas Polio Vaccine Consumption Market Share by Application (2015-2020)

Table 36. APAC Polio Vaccine Consumption by Countries (2015-2020) (M Doses)

Table 37. APAC Polio Vaccine Consumption Market Share by Countries (2015-2020)

Table 38. APAC Polio Vaccine Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Polio Vaccine Value Market Share by Regions (2015-2020)

Table 40. APAC Polio Vaccine Consumption by Type (2015-2020) (M Doses)

Table 41. APAC Polio Vaccine Consumption Market Share by Type (2015-2020)

Table 42. APAC Polio Vaccine Consumption by Application (2015-2020) (M Doses)

Table 43. APAC Polio Vaccine Consumption Market Share by Application (2015-2020)

Table 44. Europe Polio Vaccine Consumption by Countries (2015-2020) (M Doses)

Table 45. Europe Polio Vaccine Consumption Market Share by Countries (2015-2020)

Table 46. Europe Polio Vaccine Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Polio Vaccine Value Market Share by Countries (2015-2020)

Table 48. Europe Polio Vaccine Consumption by Type (2015-2020) (M Doses)

Table 49. Europe Polio Vaccine Consumption Market Share by Type (2015-2020)

Table 50. Europe Polio Vaccine Consumption by Application (2015-2020) (M Doses)

Table 51. Europe Polio Vaccine Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Polio Vaccine Consumption by Countries (2015-2020) (M Doses)

Table 53. Middle East & Africa Polio Vaccine Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Polio Vaccine Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Polio Vaccine Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Polio Vaccine Consumption by Type (2015-2020) (M Doses)

Table 57. Middle East & Africa Polio Vaccine Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Polio Vaccine Consumption by Application (2015-2020) (M Doses)

Table 59. Middle East & Africa Polio Vaccine Consumption Market Share by Application (2015-2020)

Table 60. Polio Vaccine Distributors List

Table 61. Polio Vaccine Customer List

Table 62. Global Polio Vaccine Consumption Forecast by Countries (2021-2025) (M Doses)

Table 63. Global Polio Vaccine Consumption Market Forecast by Regions

Table 64. Global Polio Vaccine Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Polio Vaccine Value Market Share Forecast by Regions

Table 66. Global Polio Vaccine Consumption Forecast by Type (2021-2025) (M Doses)

Table 67. Global Polio Vaccine Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Polio Vaccine Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Polio Vaccine Value Market Share Forecast by Type (2021-2025)

Table 70. Global Polio Vaccine Consumption Forecast by Application (2021-2025) (M Doses)

Table 71. Global Polio Vaccine Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Polio Vaccine Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Polio Vaccine Value Market Share Forecast by Application (2021-2025)

Table 74. Sanofi Product Offered

Table 75. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 76. Sanofi Main Business

Table 77. Sanofi Latest Developments

Table 78. Sanofi Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 79. GSK Product Offered

Table 80. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 81. GSK Main Business

Table 82. GSK Latest Developments

Table 83. GSK Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 84. Serum Institute Product Offered

Table 85. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 86. Serum Institute Main Business

Table 87. Serum Institute Latest Developments

Table 88. Serum Institute Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 89. Tiantan Biological Product Offered

Table 90. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 91. Tiantan Biological Main Business

Table 92. Tiantan Biological Latest Developments

Table 93. Tiantan Biological Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. Bibcol Product Offered

Table 95. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 96. Bibcol Main Business

Table 97. Bibcol Latest Developments

Table 98. Bibcol Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Bio-Med Product Offered

Table 100. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 101. Bio-Med Main Business

Table 102. Bio-Med Latest Developments

Table 103. Bio-Med Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. IMBCA Product Offered

Table 105. IMBCA Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 106. IMBCA Main Business

Table 107. IMBCA Latest Developments

Table 108. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 109. Halfkin Bio-Pharmaceuticals Product Offered

Table 110. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 111. Halfkin Bio-Pharmaceuticals Main Business

Table 112. Halfkin Bio-Pharmaceuticals Latest Developments

Table 113. Halfkin Bio-Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. Panacea Biotec Ltd Product Offered

Table 115. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)

Table 116. Panacea Biotec Ltd Main Business

Table 117. Panacea Biotec Ltd Latest Developments

Table 118. Panacea Biotec Ltd Basic Information, Company Total Revenue (in $ million), Polio Vaccine Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Polio Vaccine

Figure 2. Polio Vaccine Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Polio Vaccine Consumption Growth Rate 2015-2025 (M Doses)

Figure 5. Global Polio Vaccine Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Inactivated Polio Vaccine (IPV)

Figure 7. Product Picture of Oral Polio Vaccine (OPV)

Figure 8. Global Polio Vaccine Consumption Market Share by Type (2015-2020)

Figure 9. Global Polio Vaccine Value Market Share by Type (2015-2020)

Figure 10. Polio Vaccine Consumed in Public

Figure 11. Global Polio Vaccine Market: Public (2015-2020) (M Doses)

Figure 12. Global Polio Vaccine Market: Public (2015-2020) ($ Millions)

Figure 13. Polio Vaccine Consumed in Private

Figure 14. Global Polio Vaccine Market: Private (2015-2020) (M Doses)

Figure 15. Global Polio Vaccine Market: Private (2015-2020) ($ Millions)

Figure 16. Global Polio Vaccine Consumption Market Share by Application (2015-2020)

Figure 17. Global Polio Vaccine Value Market Share by Application (2015-2020)

Figure 18. Global Polio Vaccine Sales Market Share by Company in 2017

Figure 19. Global Polio Vaccine Sales Market Share by Company in 2019

Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2017

Figure 21. Global Polio Vaccine Revenue Market Share by Company in 2019

Figure 22. Global Polio Vaccine Sale Price by Company in 2019

Figure 23. Global Polio Vaccine Consumption Market Share by Regions 2015-2020

Figure 24. Global Polio Vaccine Value Market Share by Regions 2015-2020

Figure 25. Americas Polio Vaccine Consumption 2015-2020 (M Doses)

Figure 26. Americas Polio Vaccine Value 2015-2020 ($ Millions)

Figure 27. APAC Polio Vaccine Consumption 2015-2020 (M Doses)

Figure 28. APAC Polio Vaccine Value 2015-2020 ($ Millions)

Figure 29. Europe Polio Vaccine Consumption 2015-2020 (M Doses)

Figure 30. Europe Polio Vaccine Value 2015-2020 ($ Millions)

Figure 31. Middle East & Africa Polio Vaccine Consumption 2015-2020 (M Doses)

Figure 32. Middle East & Africa Polio Vaccine Value 2015-2020 ($ Millions)

Figure 33. Americas Polio Vaccine Consumption Market Share by Countries in 2019

Figure 34. Americas Polio Vaccine Value Market Share by Countries in 2019

Figure 35. Americas Polio Vaccine Consumption Market Share by Type in 2019

Figure 36. Americas Polio Vaccine Consumption Market Share by Application in 2019

Figure 37. United States Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 38. United States Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 39. Canada Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 40. Canada Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 41. Mexico Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 42. Mexico Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 43. APAC Polio Vaccine Consumption Market Share by Countries in 2019

Figure 44. APAC Polio Vaccine Value Market Share by Regions in 2019

Figure 45. APAC Polio Vaccine Consumption Market Share by Type in 2019

Figure 46. APAC Polio Vaccine Consumption Market Share by Application in 2019

Figure 47. China Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 48. China Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 49. Japan Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 50. Japan Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 51. Korea Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 52. Korea Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 53. Southeast Asia Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 54. Southeast Asia Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 55. India Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 56. India Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 57. Australia Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 58. Australia Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 59. Europe Polio Vaccine Consumption Market Share by Countries in 2019

Figure 60. Europe Polio Vaccine Value Market Share by Countries in 2019

Figure 61. Europe Polio Vaccine Consumption Market Share by Type in 2019

Figure 62. Europe Polio Vaccine Consumption Market Share by Application in 2019

Figure 63. Germany Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 64. Germany Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 65. France Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 66. France Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 67. UK Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 68. UK Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 69. Italy Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 70. Italy Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 71. Russia Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 72. Russia Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 73. Middle East & Africa Polio Vaccine Consumption Market Share by Countries in 2019

Figure 74. Middle East & Africa Polio Vaccine Value Market Share by Countries in 2019

Figure 75. Middle East & Africa Polio Vaccine Consumption Market Share by Type in 2019

Figure 76. Middle East & Africa Polio Vaccine Consumption Market Share by Application in 2019

Figure 77. Egypt Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 78. Egypt Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 79. South Africa Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 80. South Africa Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 81. Israel Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 82. Israel Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 83. Turkey Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 84. Turkey Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 85. GCC Countries Polio Vaccine Consumption Growth 2015-2020 (M Doses)

Figure 86. GCC Countries Polio Vaccine Value Growth 2015-2020 ($ Millions)

Figure 87. Global Polio Vaccine Consumption Growth Rate Forecast (2021-2025) (M Doses)

Figure 88. Global Polio Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 89. Americas Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 90. Americas Polio Vaccine Value 2021-2025 ($ Millions)

Figure 91. APAC Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 92. APAC Polio Vaccine Value 2021-2025 ($ Millions)

Figure 93. Europe Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 94. Europe Polio Vaccine Value 2021-2025 ($ Millions)

Figure 95. Middle East & Africa Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 96. Middle East & Africa Polio Vaccine Value 2021-2025 ($ Millions)

Figure 97. United States Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 98. United States Polio Vaccine Value 2021-2025 ($ Millions)

Figure 99. Canada Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 100. Canada Polio Vaccine Value 2021-2025 ($ Millions)

Figure 101. Mexico Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 102. Mexico Polio Vaccine Value 2021-2025 ($ Millions)

Figure 103. Brazil Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 104. Brazil Polio Vaccine Value 2021-2025 ($ Millions)

Figure 105. China Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 106. China Polio Vaccine Value 2021-2025 ($ Millions)

Figure 107. Japan Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 108. Japan Polio Vaccine Value 2021-2025 ($ Millions)

Figure 109. Korea Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 110. Korea Polio Vaccine Value 2021-2025 ($ Millions)

Figure 111. Southeast Asia Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 112. Southeast Asia Polio Vaccine Value 2021-2025 ($ Millions)

Figure 113. India Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 114. India Polio Vaccine Value 2021-2025 ($ Millions)

Figure 115. Australia Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 116. Australia Polio Vaccine Value 2021-2025 ($ Millions)

Figure 117. Germany Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 118. Germany Polio Vaccine Value 2021-2025 ($ Millions)

Figure 119. France Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 120. France Polio Vaccine Value 2021-2025 ($ Millions)

Figure 121. UK Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 122. UK Polio Vaccine Value 2021-2025 ($ Millions)

Figure 123. Italy Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 124. Italy Polio Vaccine Value 2021-2025 ($ Millions)

Figure 125. Russia Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 126. Russia Polio Vaccine Value 2021-2025 ($ Millions)

Figure 127. Spain Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 128. Spain Polio Vaccine Value 2021-2025 ($ Millions)

Figure 129. Egypt Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 130. Egypt Polio Vaccine Value 2021-2025 ($ Millions)

Figure 131. South Africa Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 132. South Africa Polio Vaccine Value 2021-2025 ($ Millions)

Figure 133. Israel Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 134. Israel Polio Vaccine Value 2021-2025 ($ Millions)

Figure 135. Turkey Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 136. Turkey Polio Vaccine Value 2021-2025 ($ Millions)

Figure 137. GCC Countries Polio Vaccine Consumption 2021-2025 (M Doses)

Figure 138. GCC Countries Polio Vaccine Value 2021-2025 ($ Millions)

Figure 139. Sanofi Polio Vaccine Market Share (2018-2020)

Figure 140. GSK Polio Vaccine Market Share (2018-2020)

Figure 141. Serum Institute Polio Vaccine Market Share (2018-2020)

Figure 142. Tiantan Biological Polio Vaccine Market Share (2018-2020)

Figure 143. Bibcol Polio Vaccine Market Share (2018-2020)

Figure 144. Bio-Med Polio Vaccine Market Share (2018-2020)

Figure 145. IMBCA Polio Vaccine Market Share (2018-2020)

Figure 146. Halfkin Bio-Pharmaceuticals Polio Vaccine Market Share (2018-2020)

Figure 147. Panacea Biotec Ltd Polio Vaccine Market Share (2018-2020)